Wan, Y., & Evans, R. M. (2010). Rosiglitazone activation of PPARγ suppresses fractalkine signaling. Society for Endocrinology.
Chicago Style CitationWan, Yihong, i Ronald M. Evans. Rosiglitazone Activation of PPARγ Suppresses Fractalkine Signaling. Society for Endocrinology, 2010.
Cita MLAWan, Yihong, i Ronald M. Evans. Rosiglitazone Activation of PPARγ Suppresses Fractalkine Signaling. Society for Endocrinology, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.